Modeling and Simulation - PK/PD Archives | 第 12 页，共 37 页 | Certara

Publication

Evaluation of Dosing Strategy for Pembrolizumab for Oncology Indications

webdev2017 年 5 月 1 日

Publication

Effect of Disease-related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats

webdev2017 年 5 月 1 日

Publication

Isoniazid Clearance is Impaired Among Human Immunodeficiency Virus/Tuberculosis Patients with High Levels of Immune Activation

webdev2017 年 4 月 1 日

Blog

The Model-informed Precision Dosing Revolution Is Coming

Modeling and simulation (M&S) has been widely accepted and adopted by biopharmaceutical companies and global…

Certara2017 年 3 月 7 日

Publication

CYP2C9 Genotype-dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites

webdev2017 年 3 月 1 日

Publication

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

webdev2017 年 1 月 10 日

Publication

Clarification of Contraceptive Drug Pharmacokinetics in Obesity

webdev2017 年 1 月 1 日

Publication

Population Pharmacokinetics and Exposure-response of Osimertinib in Patients with Non-small Cell Lung Cancer

webdev2016 年 12 月 18 日

Brochure

Phoenix IVIVC 工具箱

探索 IVIVC Toolkit 的全面功能。

webdev2016 年 12 月 14 日

Publication

Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy

webdev2016 年 12 月 5 日

© 2025 Certara. 保留所有权力。 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software